○Nao Miyata1, Hiroshi Sakane1, Junna Urabe1, Saki Nakahira1, Katsumi Hino1, Kenji Akasaki1 (1. Faculty of Pharm. and Pharm. Sci., Fukuyama Univ.)
Session information
Poster Presentation
(C) Biochemistry
[28P02] 細胞の構造と機能②
Sun. Mar 28, 2021 9:00 AM - 6:00 PM [Room P02] Poster Presentation (Online)
○Keisuke Sato1, Manae Ito1, Syoya Endo1, Kazuma Kido1, Ryosuke Tatsunami1 (1. Dept. Pharm., Fac. Pharm. Sci., Hokkaido Univ. Sci.)
○Eiko Satoh1, Mana Ikeda1, Tatsuo Takahashi1, Shinjiro Kobayashi1, Masaaki Nomura1 (1. Fac. Pharm. Sci., Hokuriku Univ.)
○Natsumi Miyazaki1, Reika Shiratori1, Shigeki Aoki1 (1. Lab. of Biopharm., Fac. of Pharm. Sci., Chiba Univ.)
○Jun Kamishikiryo1, Tomoyasu Fujii1, Tetsuo Morita1 (1. Dept. Biochem. Fac. Pharm. Pharmaceut. Sci., Fukuyama Univ.)
○Mai Ebisu1, Akiho Kurita1, Rie Sasaki1, Ryoko Takasawa1 (1. Facul. Pharm. Sci., Tokyo Univ. Sci.)
○Natsuki Miyazaki1, Kanako Nakamine1, Mio Takahashi1, Atsushi Yoshimori2, Ryoko Takasawa1 (1. Facul. Pharm. Sci., Tokyo Univ. Sci., 2. ITM. Inc.)
○Kiyomi Hikita1, Tomiyasu Murata1, Tomoki Nakayoshi1, Akifumi Oda1, Naoki Asao2, Shingo Dan3, Norio Kaneda1 (1. Fac. Pharm., Meijo Univ., 2. Grad. Sch. Sci. Technol., Shinshu Univ., 3. Cancer Chemother. center, JFCR)
○Takeo Tatsuta Tatsuta1, Arisu Nakasato1, Shigeki Sugawara1, Masahiro Hosono1 (1. Div. of Cell Recog., Tohoku Med. Pharm. Univ.)
[28P02-181S] Exploration of the novel parthanatos inhibitors for treating neurodegenerative diseases
○Shuhei Hamano1, Midori Suzuki1, Yukino Asai1, Yusuke Hirata1, Takuya Noguchi1, Atsushi Matsuzawa1 (1. Lab. of Health Chem., Grad. Sch. of Pharmaceut. Sci., Tohoku Univ.)
○Hiromu Komatsu1, Yusuke Hirata1, Takuya Noguchi1, Atsushi Matsuzawa1 (1. Lab. of Health Chem., Grad. Sch. of Pharmaceut. Sci., Tohoku Univ.)
Withdrawn
○Kiyoshiro Nakamura1, Kohichi Kawahara1, Tatsuhiko Furukawa1 (1. Dept. Mol. Oncol., Grad. Sch. of Med. and Dent. Sci., Kagoshima Univ.)
○Koichi Sakurai1, Kana Hashimoto1, Ryota Mayama1, Sanae Hirayama1 (1. Division of Life Science, Department of Pharmacy, Hokkaido University of Science.)
○Ryoichi Yabuki1, Shohei Yamamoto1, Shoji Hata1, Daiju Kitagawa1 (1. Grad. Sch. Pharm. Sci., The Univ. of Tokyo)
[28P02-187S] CEP76 suppresses the aberrant activation of PLK1 and ensures proper mitotic progression
○Yutaka Takeda1, Kaho Yamazaki1, Kaho Hashimoto1, Koki Watanabe1, Takumi Chinen1, Daiju Kitagawa1 (1. Grad. Sch. Pharm. Sci., The University of Tokyo.)
○Ryoko Ota1, Mayue Hongo1, Misaki Okada1, Takahisa Kuga1, Ryuzaburo Yuki1, Youhei Saito1, Yuji Nakayama1 (1. Kyoto Pharmaceutical Univ.)
○Takao Toyomura1, Masahiro Watanabe1, Hidenori Wake2, Daiki Ousaka3, Dengri Wang3, Hideo Takahashi2, Masahiro Nishibori3, Shuji Mori1 (1. Sch. of Pharm., Shujitsu Univ., 2. Fac. of Med., Kindai Univ., 3. Grad. Sch. of Med., Dent. and Pharm. Sci., Okayama Univ.)
○Yuta Yoshino1, Tatsuki Teruya1, Haruka Matsunaga1, Yoshinobu Ishikawa2, Akira Ikari1 (1. Laboratory of Biochemistry, Department of Biopharmaceutical Sciences, Gifu Pharmaceutical University, 2. Department of Physical Biochemistry, School of Pharmaceutical Sciences, University of Shizuoka)
○Ayaka Ito1, Nasako Haruka1, Yui Takashina1, Hiroaki Eguchi1, Yoshinobu Ishikawa2, Toshiyuki Matsunaga3, Satoshi Endo1, Akira Ikari1 (1. Lab. of Biochem. Sci, Dept. of Biopharm, Gifu Pharm. Univ., 2. Dept. of Phys. Biochem, Schl. of Pharm. Sci, Univ. of Shizuoka, 3. Edu. Ctr. of Green Pharm. Sci, Gifu Pharm. Univ.)
○Maina Yamaguchi1, Shunsuke Minato1, Misaki Noguchi1, Kazuhisa Ota1, Shinya Takazaki1 (1. Fac. of Pharm. Sci., Nagasaki Itn. Univ.)
○Takanobu Kobayashi1, Takayuki Ohshima1, Iori Isozaki1, Rina Hiraoka1, Katsuhito Kino1, Hiroshi Miyazawa1 (1. Kagawa Sch. Pharm. Sci., Tokushima Bunri Univ.)
○Toshiyuki Oshima1, Tomofumi Fujino1, Makio Hayakawa1 (1. Sch. Pharm. Hygiene & Health Sci., Tokyo Univ. Pharm. Life & Sci. )
○Eno Iwasaki1, Naoyuki Iida1, Mitsuru Okuwaki1 (1. Dept. Biochem., Sch. of Pharm. Sci., Kitasato Univ.)
○Tsugumi Takeo1, Masateru Miyake2, Hideya Mizuno1 (1. Sch. Pharm. Sci., Mukogawa Women’s Univ., 2. Pharmacovigilance Department, Otsuka Pharmaceutical Co. Ltd.)
○Kazushi Fujiwara1, Risa Komatsu1, Yukina Noguchi1, Tatsuya Yokoyama1, Kaoru Kinosita1, Kazuhiko Nakadate1, Kenji Hattori1, Kazuyuki Isii1 (1. Meiji Pharmaceutical Univ.)
○Hiroto Shimoji1, masayori Hagimori2, Keitaro Tanaka1, Tatsusada Yoshida1, Yasuhisa Nishimura3, Yukiko Ogawa1 (1. Fucl.Pharm.Sci.,Nagasaki Int.Univ., 2. Sch. Pharm., Mukogawa Women's Univ., 3. Sch. Eng., Nagasaki Univ. ,)
○Yuko Ogawa1, Anna Ishikawa1, Sakura Ohta1, Mamoru Ikemoto1, Yoshikuni Goto1, Yoshihiro Akimoto2, Hayato Kawakami2, Masafumi Tsujimoto1, Ryohei Yanoshita1 (1. Dept. Pharm. Sci., Teikyo Heisei Univ., 2. Sch. Med., Kyorin Univ.)
○Nao Yamagishi1, Jun-ichiro Takahashi1, Yue Zhou1, Satoru Yokoyama1, Hiroaki Sakurai1 (1. Grad. Sch. Pharm. Sci., Univ. Toyama)
Ayaka Ebina1,3, Chisaki Yoshida1,3, Masaharu Nomura2, ○Hinako Suga1 (1. Life Environ. Sci., Showa Women's Univ., 2. Shingo Central Clinic, 3. These authors contributed equally)
○Mina Kanai1, Nana Fukuoka2, Tomohiro Yano3 (1. Food and Nutritional Sci., Toyo Univ., 2. Grad. Sch. Food and Nutritional Sci., Toyo Univ., 3. Res. Inst. Life Innovation, Toyo Univ.)